Intellia Therapeutics, Inc. (NTLA)

Intellia Therapeutics Stock Forecast

Stock Price Forecast

The 20 analysts that cover Intellia Therapeutics stock have a consensus rating of "Buy" and an average price target of $32.3, which forecasts a 175.36% increase in the stock price over the next year. The lowest target is $10 and the highest is $64.

Price Target: $32.3 (+175.36%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$10	$32.3	$30	$64
Change	-14.75%	+175.36%	+155.75%	+445.61%

Analyst Ratings

The average analyst rating for Intellia Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Apr '25	May '25	Jun '25	Jul '25	Aug '25	Sep '25
Strong Buy	6	7	7	7	8	8
Buy	7	7	7	7	6	6
Hold	6	6	6	6	6	6
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	19	20	20	20	20	20

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Geulah Livshits Chardan Capital	Chardan Capital	Strong Buy Maintains $68 → $60	Strong Buy	Maintains	$68 → $60	+411.51%	Aug 11, 2025
Luca Issi RBC Capital	RBC Capital	Buy Maintains $25 → $21	Buy	Maintains	$25 → $21	+79.03%	Aug 8, 2025
Yanan Zhu Wells Fargo	Wells Fargo	Buy Maintains $50 → $45	Buy	Maintains	$50 → $45	+283.63%	Aug 8, 2025
Mitchell S. Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $30 → $25	Strong Buy	Maintains	$30 → $25	+113.13%	Aug 8, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $30	Strong Buy	Reiterates	$30	+155.75%	Jun 16, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

62.69M

Increased by 8.32%

from 57.88M

Revenue Next Year

53.27M

Decreased by -15.03%

from 62.69M

EPS This Year

-4.17

from -5.25

EPS Next Year

-3.97

from -4.17

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	57.99M	33.05M	52.12M	36.28M	57.88M	62.69M	53.27M
Revenue Growth	34.55%	-43.01%	57.69%	-30.40%	59.55%	8.32%	-15.03%
EPS	-2.40	-3.78	-6.16	-5.42	-5.25	-4.17	-3.97
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	28	27

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	220.5M	105.0M
Avg	62.7M	53.3M
Low	30.3M	6.9M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	281.0%	67.5%
Avg	8.3%	-15.0%
Low	-47.7%	-89.1%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-2.80	-2.49
Avg	-4.17	-3.97
Low	-4.65	-4.95

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.